Search

everythinglearnresearchcommunity

for

Search:↓

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Leontopodium alpinum extract may help reduce hair shedding by keeping hair in the growth phase longer.

Hair graying is influenced by factors like nerves, fat cells, and immune cells, not just hair follicles.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Some plants with flavonoids may help treat hair loss and promote hair growth.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

N,N-Dimethylglycine Sodium Salt helps reduce skin inflammation and improves skin cell growth and healing.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Activating Nrf2 in skin cells causes skin disease similar to chloracne in mice.

Notch/CSL signaling controls hair follicle differentiation through Wnt5a and FoxN1.

Cetuximab can cause excessive eyelash growth.

Platelet-rich Plasma Gel may help treat en coup de sabre scleroderma, improving symptoms and skin quality with minimal side effects.

Apremilast shows promise for several skin conditions but needs more research.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

TNF-alpha inhibitors can cause various immune-related skin issues.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

PRP treatment may help with alopecia areata, especially in newer cases.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Barley extract, specifically procyanidin B-3, can promote hair growth and counteract growth inhibition.

Wnt5a may contribute to psoriasis by reducing skin cell growth, blocking skin cell maturation, and increasing inflammation.

Metformin may help treat neuroendocrine tumors.